Kelly provides clear, strategic advice, helping clients navigate challenges and minimise disruption caused by disputes and regulatory action.
Biography
Kelly specialises in complex regulatory investigations and enforcement proceedings, royal commissions, parliamentary inquiries and commercial litigation, including class actions. She has acted in reputationally significant regulatory matters, including multi-jurisdictional investigations.
Kelly advises clients operating in regulated sectors, including financial services, healthcare, life sciences, energy, chemicals, manufacturing, technology and transport.
She has extensive experience in government inquiries and advises clients on public policy, legislative reform and advocacy strategies. Kelly served on the Medicines Australia taskforce that negotiated the 2018 Strategic Agreement with the Federal Government.
Her work spans complex commercial disputes, contract disputes, shareholder disputes, Corporations Act matters, advertising and consumer law, IP, product liability, torts and administrative law. She provides strategic advice across financial services regulation, accountability and integrity (including anti-bribery and sanctions), and therapeutic goods regulation (including market access strategies).
Kelly is an experienced director in the healthcare and creative industries. She serves on Human Research Ethics Committees at the Royal Children's Hospital and the Murdoch Children's Research Institute, advisory committees to the Victorian Health Complaints Commissioner, Emergency Management Victoria and WorkSafe Victoria, and is the therapeutic goods regulatory expert for LexisNexis.
Kelly's experience
-
Global Capital Property Fund
Advised on a $180m ASIC investigation and proceedings alleging multiple Corporations Act 2001 (Cth) breaches, involving director duties, hawking prohibitions, licensee obligations, disclosure requirements and alleged misleading statements. -
Australian Health Practitioners Regulation Agency
Advised AHPRA and the National Boards in connection with enforcement proceedings that arise under the Health Practitioner Regulation National Law. -
BioMelbourne Network
Drafted a key industry submission to the Commonwealth's consultation on introducing a patent box tax incentive for biomedical innovation. -
Grace and Fire (trading as Ultra Violette)
Advised one of Australia's most innovative sunscreen companies in connection with testing of sunscreens undertaken by CHOICE Magazine, including voluntary product recall and engagement with the Therapeutic Goods Administration. -
Juno Pharmaceuticals
Prepared influential submissions to the Federal Government's inquiry into the Efficient Funding of Chemotherapy Program, impacting national reimbursement policy. -
KDR Victoria (Keolis Downer)
Advised KDR, the operator of the world's largest tram network under a contract with the State of Victoria, on all transition and close-out related activities when the contract was awarded to a new operator in 2024. -
Energy company
Advised on an ASIC investigation into greenwashing allegations resulting in no further action.
Awards, recognition and rankings
- Best Lawyers in Australia 2027 – Recognised for Litigation and Health and Aged Care